ENTRY       D11685                      Drug
NAME        Pegunigalsidase alfa (USAN/INN);
            Pegunigalsidase alfa-iwxj;
            Elfabrio (TN)
PRODUCT     ELFABRIO (Chiesi USA)
FORMULA     C2060H3130N552O601S27
EXACT_MASS  46080.3788
MOL_WEIGHT  46109.987
SEQUENCE    GLDNGLARTP TMGWLHWERF MCNLDCQEEP DSCISEKLFM EMAELMVSEG WKDAGYEYLC
            IDDCWMAPQR DSEGRLQADP QRFPHGIRQL ANYVHSKGLK LGIYADVGNK TCAGFPGSFG
            YYDIDAQTFA DWGVDLLKFD GCYCDSLENL ADGYKHMSLA LNRTGRSIVY SCEWPLYMWP
            FQKPNYTEIR QYCNHWRNFA DIDDSWKSIK SILDWTSFNQ ERIVDVAGPG GWNDPDMLVI
            GNFGLSWNQQ VTQMALWAIM AAPLFMSNDL RHISPQAKAL LQDKDVIAIN QDPLGKQGYQ
            LRQGDNFEVW ERPLSGLAWA VAMINRQEIG GPRSYTIAVA SLGKGVACNP ACFITQLLPV
            KRKLGFYEWT SRLRSHINPT GTVLLQLENT MQMSLKDLLS EKDEL
  TYPE      Peptide
REMARK      ATC code: A16AB20
            Product: D11685<US>
EFFICACY    Lysosomal storage disease treatment, Enzyme replacement (alpha-galactosidase)
  DISEASE   Fabry disease [DS:H00125]
  TYPE      Enzyme replacement therapy product
COMMENT     Treatment of Fabry disease
TARGET      GLA* [HSA_VAR:2717v1] [HSA:2717] [KO:K01189]
  PATHWAY   hsa00600(2717)  Sphingolipid metabolism
            hsa04142(2717)  Lysosome
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
               A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
                A16AB Enzymes
                 A16AB20 Pegunigalsidase alfa
                  D11685  Pegunigalsidase alfa (USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
              Pegunigalsidase Alfa
               D11685  Pegunigalsidase alfa (USAN/INN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Glycosidases
                GLA* [HSA_VAR:2717v1]
                 D11685  Pegunigalsidase alfa (USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11685
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11685
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11685
            Pharmacogenomic biomarkers [br08341.html]
             Germline mutations in genetic disorder treatments
              D11685
DBLINKS     CAS: 1644392-61-9
            PubChem: 405226551
///
